Article Details

FibroGen's longtime CFO hands baton to J&J veteran as high-profile roxadustat blowup cues a ...

Retrieved on: 2021-08-16 15:22:30

Tags for this article:

Click the tags to see associated articles and topics

FibroGen's longtime CFO hands baton to J&J veteran as high-profile roxadustat blowup cues a .... View article details on hiswai:

Excerpt

The latest transition comes as the San Francisco biotech grapples with the FDA rejection of its AstraZeneca-partnered anemia drug roxadustat.

Article found on: www.fiercepharma.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up